Results 191 to 200 of about 147,721 (313)

Comparative atrial fibrillation risk across Bruton's tyrosine kinase inhibitors in B‐cell malignancies: A nationwide population‐based study

British Journal of Haematology, EarlyView.
Real‐world nationwide data in B‐cell malignancies reveal a markedly increased 1‐year incidence of hospitalized atrial fibrillation with ibrutinib compared with second‐generation Bruton's tyrosine kinase inhibitors and venetoclax, arguing for closer cardiac surveillance.
Yoann Zelmat, Loic Ysebaert, Paul Gautier, Agnes Sommet, Margaux Lafaurie, Fabien Despas   +5 more
wiley   +1 more source

Portal Vein Thrombosis Due to Concomitant Cytomegalovirus and Epstein-Barr Virus Infection: An Underestimated Complication. [PDF]

Am J Case Rep
AlQahtani SY.
europepmc   +1 more source

International Delphi consensus on feminising genital surgery in assigned‐male‐at‐birth individuals

BJU International, EarlyView.
Objective To achieve an international expert consensus among surgeons on the indications, contraindications, and perioperative management of feminising genital surgery (FGS) for assigned‐male‐at‐birth (AMAB) individuals, using a Delphi process. Methods A two‐round on‐line Delphi survey (May–July 2025) followed by a final consensus meeting (September ...
Marta Pezzoli, Mattia Lo Re, Valeria Pizziconi, Marco Falcone, Mirko Preto, Marco Capece, Michele Rizzo, Guglielmo Mantica, Francesco Chierigo, Malte Vetterlein, Patrizio Vicini, François‐Xavier Madec, Paul Neuville, Wai Gin (Don) Lee, Francesca Vedovo, Saskia Morgenstern, Marjan Waterloos, Miroslav Djordjevic, Wesley Verla, Lukasz Bialek, Juan Diego Tinajero, Jordán Scherñuk, Tim Ludwig, Silke Riechardt, Lisa Szyper, Maren Wenk, Jochen Heß, Julia Bohr, Andrea Minervini, Andrea Cocci, on behalf of the Italian Society of Urodynamics (SIUD)   +30 more
wiley   +1 more source

Acute massive pulmonary thromboembolism caused by cord-like foreign bodies in the heart and pulmonary arteries after percutaneous vertebroplasty: a case report and literature review. [PDF]

Front Med (Lausanne)
Zou F, Cui Y, Qu L, Wu J.
europepmc   +1 more source

Renal‐vascular axis: unmasking its role in vascular endothelial growth factor‐inhibitor vascular toxicity in cancer patients

British Journal of Pharmacology, EarlyView.
Abstract Vascular toxicity is a growing concern in cancer patients receiving vascular endothelial growth factor inhibitor (VEGFi) therapy, posing a significant threat to patient prognosis. While the primary mechanism of VEGFi‐induced vascular toxicity is linked to redox‐sensitive reactions that disrupt vascular tone, leading to hypertension and ...
Grace Whelan, Karla B. Neves
wiley   +1 more source

The risk of venous thromboembolism in kidney transplant recipients is enhanced following a cytomegalovirus infection. [PDF]

Front Immunol
Masset C, Lorent M, Le Borgne F, Scemla A, Kerleau C, Bressollette-Bodin C, Morelon E, Charmetant X, Lequintrec-Donnette M, Pernin V, Ladrière M, Girerd S, Aubert O, Legendre C, Sicard A, Albano L, Lefaucheur C, Divard G, Mariat C, Claisse G, Dantal J, Giral M.   +21 more
europepmc   +1 more source

Cardiotoxicity of BRAF/MEK inhibitors

British Journal of Pharmacology, EarlyView.
Abstract Rapidly accelerated fibrosarcoma type B/B‐Raf proto‐oncogene, serine/threonine kinase (BRAF) and mitogen‐activated protein kinase (MEK) inhibitors have transformed outcomes in cancer therapy, particularly in melanoma. However, cardiovascular toxicities are increasingly recognized in real‐world clinical practice.
Katharina Seuthe, Valerie Lohner, Kevin Terre, Thomas Riffelmacher, Roman Pfister   +4 more
wiley   +1 more source

Detected residual venous thrombi and catheter-directed management of intermediate-risk pulmonary thromboembolism. [PDF]

Front Cardiovasc Med
Heyman SN, Leibowitz D, Herzog E.
europepmc   +1 more source

Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions

Clinical Endocrinology, EarlyView.
ABSTRACT Objective To provide clinicians involved in managing menopause with a summary of current evidence surrounding menopause hormone therapy (MHT). Design The authors evaluate and synthesize existing pooled evidence relating to MHT's clinical indications, efficacy, and safety and explore the limitations of existing data. Patients The review focuses
Annice Mukherjee, Susan R. Davis
wiley   +1 more source

Lifestyle Management in Menopause: A Systematic Review of Women With Premature Ovarian Insufficiency

Clinical Endocrinology, EarlyView.
ABSTRACT Objective Premature ovarian insufficiency (POI), the loss of ovarian function before age 40, increases the risk of cardiovascular disease, low bone mineral density, dementia and psychological distress. Lifestyle interventions reduce chronic disease risk in other populations and, with hormone therapy, may improve health outcomes in POI.
Ladan Yeganeh, Nathalie Vermeulen, Carolyn Ee, Helena Teede, Amanda J. Vincent   +4 more
wiley   +1 more source